- Author(s):
- Organization(s):
Respidex, LLC
In this “letter to students,” the author sees exciting opportunities ahead for young scientists willing to take on the challenges in inhalation therapy research and development.
The author suggests opportunities exist in treating additional diseases, getting involved with patients, determining aerodynamic particle size distribution, managing oropharyngeal deposition, improving nasal delivery and targeting orally inhaled products with narrow therapeutic indices.